{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-21-000030","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2021-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.322675+00:00","generated_at":"2026-06-28T04:17:07.947917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CooperCompanies reports record FY2021 revenue; Q4 revenue up 11% to $759.1M","bullets":["Q4 revenue $759.1M (+11% YoY); GAAP EPS $2.21 (+35%); Non-GAAP EPS $3.28 (+4%)","FY2021 revenue $2,922.5M (+20%); Non-GAAP EPS $13.24 (+37%)","CooperVision rev $564.8M (+12%); CooperSurgical rev $194.3M (+11%)","FY2022 guidance: rev $3,032-3,090M (+6-8% cc); Non-GAAP EPS $13.60-14.00","Generate Life Sciences acquisition (announced Nov 10) not included in guidance"],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-21-000030","json":"https://secwatch.observer/filing/0000711404-21-000030.json","markdown":"https://secwatch.observer/filing/0000711404-21-000030.md","text":"https://secwatch.observer/filing/0000711404-21-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140421000030/0000711404-21-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140421000030/coo-20211202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:17:07.947917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}